INFOGRAPHIC: 2-year efficacy, durability and safety of intravitreal faricimab with treat-and-extend dosing up to 16 weeks in diabetic macular oedema (pooled results from YOSEMITE and RHINE).
Journal Articles
- Overview
- Research
- Identity
- View All
Overview
publication date
- July 29, 2024
has subject area
- 1103 Clinical Sciences (FoR)
- 1107 Immunology (FoR)
- 1113 Opthalmology and Optometry (FoR)
- Ophthalmology & Optometry (Science Metrix)
published in
- Eye Journal